Correlation Between Inozyme Pharma and Argenx NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Argenx NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Argenx NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and argenx NV ADR, you can compare the effects of market volatilities on Inozyme Pharma and Argenx NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Argenx NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Argenx NV.

Diversification Opportunities for Inozyme Pharma and Argenx NV

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Inozyme and Argenx is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and argenx NV ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on argenx NV ADR and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Argenx NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of argenx NV ADR has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Argenx NV go up and down completely randomly.

Pair Corralation between Inozyme Pharma and Argenx NV

Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Argenx NV. In addition to that, Inozyme Pharma is 1.72 times more volatile than argenx NV ADR. It trades about -0.73 of its total potential returns per unit of risk. argenx NV ADR is currently generating about 0.2 per unit of volatility. If you would invest  55,447  in argenx NV ADR on August 27, 2024 and sell it today you would earn a total of  5,119  from holding argenx NV ADR or generate 9.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Inozyme Pharma  vs.  argenx NV ADR

 Performance 
       Timeline  
Inozyme Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
argenx NV ADR 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in argenx NV ADR are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady technical and fundamental indicators, Argenx NV showed solid returns over the last few months and may actually be approaching a breakup point.

Inozyme Pharma and Argenx NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inozyme Pharma and Argenx NV

The main advantage of trading using opposite Inozyme Pharma and Argenx NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Argenx NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Argenx NV will offset losses from the drop in Argenx NV's long position.
The idea behind Inozyme Pharma and argenx NV ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities